Complementary, alternative medicine may have higher risk for excessive bleeding during breast cancer surgery
the ONA take:
The popularity and increased use of complementary and alternative medicine (CAM) by cancer patients is something that oncologists should be aware of because of the side effects that can occur and subsequently impact treatment for the disease.
In a recent study published in the journal Integrative Cancer Therapies, researchers from institutions in Washington state looked at a sample of 98 women with breast cancer who received integrative (CAM) therapy and compared them to a larger group of women with similar demographics and disease characteristics, but who did not receive CAM.
The results of the study, which focused on women with breast cancer who reported both an initial surgery for their cancer and who also reported using garlic, ginseng, cranberry, gingko, vitamin E, and fish or flaxseed oil, at the time of their initial surgery, showed that 16% reported using one or more herbs or supplements thought to potentially increase their risk for adverse bleeding-related outcomes at the time of their primary surgical treatment.
This number does not include the 22% of patients who reported using fish or flaxseed oil, which were once thought to increase the risk for excessive bleeding but have since been proven safe in that regard. The authors cautioned that further research is needed to better understand the risks associated with use of a variety of herbs and supplements among women approaching surgery.
Breast cancer patients using herbal supplements had increased risk for adverse bleeding-related outcomes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|